Severe Alcohol-Related Liver Disease With Features Suggestive of Cirrhosis in a Young Adult Following Short-Term High-Risk Alcohol Use: A Case Report. [PDF]
Shayo W, Han MK, Ghufran R, Lwin ZT.
europepmc +1 more source
Leveraging the chemical similarity between Ga3+ and Fe3+ as well as the antioxidant properties of quercetin, gallium–quercetin nanoparticles (GQNPs) were prepared to integrate iron homeostasis regulation, oxidative stress suppression, and mitochondrial protection for multi‐target ferroptosis inhibition in Parkinson's Disease.
Keyang Xu +12 more
wiley +1 more source
Alcohol Use Disorder Pharmacotherapy in Patients With Alcohol-Related Liver Disease: A Scoping Review. [PDF]
Jogendran M, Huynh L, Flemming JA.
europepmc +1 more source
Battery‐Inspired Electrochemical Synapses for Neuromorphic Applications
Battery‐ion‐inspired synaptic devices integrate diverse electrolyte systems (solid, ion‐gel, liquid) with transition metal oxides, two‐dimensional materials, and organic channels to regulate ion‐electron coupling. By tailoring ion transport and host interactions, these platforms enable controllable plasticity and energy‐efficient implementations for ...
Won Woo Lee +6 more
wiley +1 more source
Whole‐blood biomimetic engineering transforms liquid metal nanoparticles into a tripartite immunotherapeutic platform that orchestrates regulatory T‐cell depletion, photothermal‐induced immunogenic cell death, and activation of the stimulator of interferon genes pathway.
Nina Sang, Eijiro Miyako
wiley +1 more source
Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease. [PDF]
Eun JR, Kim SU.
europepmc +1 more source
Outcomes for patients with alcohol-related liver disease admitted to Scottish intensive care units 2010-2018. [PDF]
Shariff A +4 more
europepmc +1 more source
Association of life's essential 8 with mortalities in patients with alcohol-related liver disease. [PDF]
Zhang X +5 more
europepmc +1 more source
Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trial. [PDF]
Cook A +19 more
europepmc +1 more source

